Clinical predictors of inflammatory bowel disease in a genetically well-defined Caucasian population

Journal of Negative Results in BioMedicine

Volumn 11, Issue 1, 2012, Pages

  Kanaan, Ziad M ^a   Eichenberger, Maurice R ^a   Ahmad, Surriya ^a   Weller, Clayton ^a   Roberts, Henry ^a   Pan, Jianmin ^a   Rai, Shesh N ^a   Petras, Robert ^b   Weller Jr , E Brooks ^a   Galandiuk, Susan ^a  

^a University of Louisville School of Medicine   (United States)

^b Ameripath Institute of Gastrointestinal Pathology and Digestive Disease   (United States)

Author keywords

Crohn's disease; IGR; IL23r; Inflammatory bowel disease; NOD2; OCTN1; SNP; Ulcerative Colitis

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CIGARETTE SMOKE; GENOMIC DNA; INTERLEUKIN 23 RECEPTOR; SPACER DNA;

ADULT; ARTICLE; CAUCASIAN; CIGARETTE SMOKING; CONTROLLED STUDY; CROHN DISEASE; DISEASE PREDISPOSITION; DNA EXTRACTION; ENTERITIS; FAMILY HISTORY; FEMALE; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL RADIOGRAPHY; GENE; GENE AMPLIFICATION; GENE FREQUENCY; GENE INTERACTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HEALTH SURVEY; HISTOPATHOLOGY; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; ORGANIC CATION TRANSPORTER NOVEL TYPE 1 GENE; POLYMERASE CHAIN REACTION; RISK FACTOR; RURAL AREA; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS; ALLELE; CLASSIFICATION; GENETIC PREDISPOSITION; GENETICS; MULTIVARIATE ANALYSIS; STATISTICAL MODEL; UNITED STATES;

ADULT; ALLELES; COLITIS, ULCERATIVE; CROHN DISEASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INFLAMMATORY BOWEL DISEASES; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; UNITED STATES;

EID: 84856055288     PISSN: None     EISSN: 14775751     Source Type: Journal    
DOI: 10.1186/1477-5751-11-7     Document Type: Article

References (36)

1. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Loftus EV Jr, Gastroenterology 2004 126 1504 1517 10.1053/j.gastro.2004.01.063 15168363 (Pubitemid 38649869)
2. Inflammatory bowel disease. Martins NB, Peppercorn MA, Am J Manag Care 2004 10 544 552 15352530 (Pubitemid 39097144)
3. Smoking and inflammatory bowel disease: a meta-analysis. Mahid SS, Minor KS, Soto RE, Hornung CA, Galandiuk S, Mayo Clin Proc 2006 81 1462 1471 10.4065/81.11.1462 17120402 (Pubitemid 44687433)
4. CARD15 genotype-phenotype relationships in a small inflammatory bowel disease population with severe disease affection status. Crawford NP, Colliver DW, Eichenberger MR, Funke AA, Kolodko V, Cobbs GA, et al. Dig Dis Sci 2007 52 2716 2724 10.1007/s10620-006-9208-z 17404888 (Pubitemid 47373871)
5. Inflammatory bowel disease and African Americans: a systematic review. Mahid SS, Mulhall AM, Gholson RD, Eichenberger MR, Galandiuk S, Inflamm Bowel Dis 2008 14 960 967 10.1002/ibd.20389 18266229
6. Crohn's disease patients carrying Nod2/CARD15 gene variants have an increased and early need for first surgery due to stricturing disease and higher rate of surgical recurrence. Alvarez-Lobos M, Arostegui JI, Sans M, Tassies D, Plaza S, Delgado S, et al. Ann Surg 2005 242 693 700 10.1097/01.sla.0000186173. 14696.ea 16244543 (Pubitemid 41567125)
7. Genotype-phenotype analysis of the Crohn's disease susceptibility haplotype on chromosome 5q31. Armuzzi A, Ahmad T, Ling KL, de SA, Cullen S, van HD, et al. Gut 2003 52 1133 1139 10.1136/gut.52.8.1133 12865271 (Pubitemid 36877425)
8. Contribution of OCTN variants within the IBD5 locus to pediatric onset Crohn's disease. Babusukumar U, Wang T, McGuire E, Broeckel U, Kugathasan S, Am J Gastroenterol 2006 101 1354 1361 10.1111/j.1572-0241.2006.00564.x 16771961 (Pubitemid 43830005)
9. Genetic association of nonsynonymous variants of the IL23R with familial and sporadic inflammatory bowel disease in women. Lin Z, Poritz L, Franke A, Li TY, Ruether A, Byrnes KA, et al. Dig Dis Sci 2010 55 739 746 10.1007/s10620-009-0782-8 19294505
10. NOD-LRR proteins: role in host-microbial interactions and inflammatory disease. Inohara, Chamaillard, McDonald C, Nunez G, Annu Rev Biochem 2005 74 355 383 10.1146/annurev.biochem.74.082803.133347 15952891 (Pubitemid 40995511)
11. Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study. Hampe J, Grebe J, Nikolaus S, Solberg C, Croucher PJ, Mascheretti S, et al. Lancet 2002 359 1661 1665 10.1016/S0140-6736(02)08590-2 12020527 (Pubitemid 34518526)
12. Inflammatory bowel disease: the role of environmental factors. Danese S, Sans M, Fiocchi C, Autoimmun Rev 2004 3 394 400 10.1016/j.autrev.2004.03.002 15288007 (Pubitemid 38993362)
13. Inflammatory bowel disease: etiology and pathogenesis. Fiocchi C, Gastroenterology 1998 115 182 205 10.1016/S0016-5085(98)70381-6 9649475 (Pubitemid 28307304)
14. Pathology of inflammatory bowel diseases (IBD): variability with time and treatment. Geboes K, Colorectal Dis 2001 3 2 12 12791013 (Pubitemid 32780892)
15. Diagnostic difficulties in inflammatory bowel disease pathology. Yantiss RK, Odze RD, Histopathology 2006 48 116 132 10.1111/j.1365-2559.2005.02248.x 16405661
16. Observer variability in the histopathological reporting of abnormal rectal biopsy specimens. Lessells AM, Beck JS, Burnett RA, Howatson SR, Lee FD, McLaren KM, et al. J Clin Pathol 1994 47 48 52 10.1136/jcp.47.1.48 8132809 (Pubitemid 24057749)
17. The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic review. Loftus EV, Schoenfeld P, Sandborn WJ, Aliment Pharmacol Ther 2002 16 51 60 10.1046/j.1365-2036.2002.01140.x 11856078 (Pubitemid 34123864)
18. Inflammatory bowel disease in Iceland, 1990-1994: a prospective, nationwide, epidemiological study. Bjornsson S, Johannsson JH, Eur J Gastroenterol Hepatol 2000 12 31 38 10.1097/00042737-200012010-00007 10656207 (Pubitemid 30072102)
19. Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Loftus EV, Silverstein MD, Sandborn WJ, Tremaine WJ, Harmsen WS, Zinsmeister AR, Gut 2000 46 336 343 10.1136/gut.46.3.336 10673294 (Pubitemid 30313384)
20. Epidemiology of inflammatory bowel disease. Loftus EV, Sandborn WJ, Gastroenterol Clin North Am 2002 31 1 20 10.1016/S0889-8553(01)00002-4 12122726 (Pubitemid 34733030)
21. Hospitalization, surgery, and readmission rates of IBD in Canada: a population-based study. Bernstein CN, Nabalamba A, Am J Gastroenterol 2006 101 110 118 10.1111/j.1572-0241.2006.00330.x 16405542 (Pubitemid 43381717)
22. Familial and sporadic inflammatory bowel disease: comparison of clinical features and serological markers in a genetically homogeneous population. Halme L, Turunen U, Helio T, Paavola P, Walle T, Miettinen A, et al. Scand J Gastroenterol 2002 37 692 698 10.1080/00365520212511 12126248 (Pubitemid 34620932)
23. Non-smoking: a feature of ulcerative colitis. Harries AD, Baird A, Rhodes J, Br Med J (Clin Res Ed) 1982 284 706 10.1136/bmj.284.6317.706 (Pubitemid 12176825)
24. Smoking and Crohn's disease. Somerville KW, Logan RF, Edmond M, Langman MJ, Br Med J (Clin Res Ed) 1984 289 954 956 10.1136/bmj.289.6450.954 (Pubitemid 14011155)
25. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, et al. Nature 2001 411 599 603 10.1038/35079107 11385576 (Pubitemid 32531408)
26. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Lesage S, Zouali H, Cezard JP, Colombel JF, Belaiche J, Almer S, et al. Am J Hum Genet 2002 70 845 857 10.1086/339432 11875755 (Pubitemid 34259301)
27. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Cuthbert AP, Fisher SA, Mirza MM, King K, Hampe J, Croucher PJ, et al. Gastroenterology 2002 122 867 874 10.1053/gast.2002.32415 11910337 (Pubitemid 34267268)
28. CARD15 genetic variation in a Quebec population: prevalence, genotype-phenotype relationship, and haplotype structure. Vermeire S, Wild G, Kocher K, Cousineau J, Dufresne L, Bitton A, et al. Am J Hum Genet 2002 71 74 83 10.1086/341124 12019468 (Pubitemid 34734709)
29. Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a metaanalysis. Economou M, Trikalinos TA, Loizou KT, Tsianos EV, Ioannidis JP, Am J Gastroenterol 2004 99 2393 2404 10.1111/j.1572-0241.2004.40304.x 15571588 (Pubitemid 40039371)
30. Contributions of IBD5, IL23R, ATG16L1, and NOD2 to Crohn's disease risk in a population-based case-control study: evidence of gene-gene interactions. Okazaki T, Wang MH, Rawsthorne P, Sargent M, Datta LW, Shugart YY, et al. Inflamm Bowel Dis 2008 14 1528 1541 10.1002/ibd.20512 18521914
31. A novel NOD2/CARD15 haplotype conferring risk for Crohn disease in Ashkenazi Jews. Sugimura K, Taylor KD, Lin YC, Hang T, Wang D, Tang YM, et al. Am J Hum Genet 2003 72 509 518 10.1086/367848 12577202 (Pubitemid 36255950)
32. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Gasche C, Scholmerich J, Brynskov J, D'Haens G, Hanauer SB, Irvine EJ, et al. Inflamm Bowel Dis 2000 6 8 15 10701144
33. Applied Biosystems. http://www.appliedbiosystems.com Accessed July, 2010
34. Fleiss JL, Levin BA, Paik MC, Statistical methods for rates and proportions Hoboken, N.J: Wiley-Interscience 3 2003
35. Agresti A, Categorical data analysis New York: Wiley 2 2002
36. The SAS System V9. Cary, NC, SAS Institute Inc 2003